Toujeo & Jardiance landed in Samsung Medical Center

Published: 2016-09-30 10:13:24

Updated: 2016-09-30 10:13:24

22 new pharmaceutical products, such as Sanofi-Aventis’ next-generation basal insulin Toujeo and Boehringer Ingelheim’s Jardiance, succeeded in newly landing in Samsung Medical Center.

According to the industry concerned on the 29^th, Samsung Medical Center recently approved usage of new drugs including Toujeo at a drug committee.

Pharmaceutical products succeeding in landing in Samsung Medi...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.